Recent Quotes (30 days)

You have no recent quotes
chg | %

Solarvest Bioenergy Inc  

(Public, CVE:SVS)   Watch this stock  
Find more results for SVS
-0.020 (-10.00%)
Sep 22 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.18 - 0.19
52 week 0.11 - 0.27
Open 0.19
Vol / Avg. 10,000.00/3,833.00
Mkt cap 4.22M
P/E     -
Div/yield     -
EPS -0.05
Shares 23.46M
Beta 1.33
Inst. own     -

Key stats and ratios

Q2 (Apr '17) 2016
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -114.44% -
Return on average equity - -
CDP Score - -


439 Helmcken St
+1-604-6843323 (Phone)
+1-604-6843350 (Fax)

Website links


Solarvest BioEnergy Inc. is a Canada-based algae technology company, which is engaged in the development of specially selected algal-based production systems to produce natural-based green commercial products, such as nutritional products, oils and biologic therapies, among others. The Company is focused on developing algae strains that are rich in Docosahexaenoic Acid/ Eicosapentaenoic Acid (DHA/EPA), which are a form of Omega 3 fatty acids used by the food enhancement and Nutraceutical markets. It is also focuses on developing algae strains that can be used to produce proteins with the first such target being a therapeutic that has use in human and animal orthopedic surgery and genetically modified algae strain that can be used to produce hydrogen. It is also focused on custom producing organic chemical-free Omega 3s and other nutritional oils. Its subsidiaries include Phycobiologics (Europe) Limited, Phyco Hydrogen Inc. and Solarvest (P.E.I.) Inc.

Officers and directors

Kenneth A. Cawkell Chairman of the Board, Secretary
Age: 65
Gerri J. Greenham President, Chief Executive Officer, Director
Joseph Heng Chief Financial Officer
William M. Cheliak Independent Director
Mark S. Ledwell Independent Director
Michael L. O'Brien Independent Director